Alcon Puts Money Where Mouth Is With Glaucoma Device Buy
This article was originally published in Clinica
Executive Summary
Barely a month after vowing to up investment in its surgical eye-care business, Novartis’ Alcon has signed a deal that will bring a new micro-stent technology into its glaucoma portfolio.